Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

5.140 -0.170 (-3.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,548,276
Open 5.200
Bid (Size) 5.200 (300)
Ask (Size) 5.210 (100)
Prev. Close 5.310
Today's Range 5.015 - 5.270
52wk Range 1.050 - 6.020
Shares Outstanding 64,465,037
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Taysha Gene Therapies Inc (NASDAQ:TSHA) Stock Slumps on Q3 Revenue Miss Despite Key Regulatory Win for TSHA-102 ↗
Taysha Gene Therapies stock fell after Q3 results, with a revenue miss overshadowing positive FDA Breakthrough Therapy designation for its Rett syndrome drug. 
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga

Performance

YTD
-2.1%
-2.1%
1 Month
-5.7%
-5.7%
3 Month
+1.6%
+1.6%
6 Month
+102.4%
+102.4%
1 Year
+173.4%
+173.4%

More News

Read More
News headline image
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Is Taysha Gene Therapies Stock Falling Friday? ↗
Via Benzinga
News headline image
Taysha Gene Therapies Stock Soars To 3-Year High After FDA Boost — Wall Street Calls Rett Drug ‘Derisked’ And Ahead Of Rivals ↗
Via Stocktwits
News headline image
What's Next: Taysha Gene Therapies's Earnings Preview ↗
Via Benzinga
News headline image
Where Taysha Gene Therapies Stands With Analysts ↗
Via Benzinga
News headline image
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews ↗
Via Benzinga
News headline image
Discover the most active stocks in Thursday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
Via Chartmill
News headline image
Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
Topics Stocks
News headline image
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy ↗
Via Stocktwits
News headline image
Which stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
Top 2 Health Care Stocks That May Keep You Up At Night This Month ↗
Via Benzinga
News headline image
What's Driving the Market Sentiment Around Taysha Gene Therapies? ↗
Via Benzinga
News headline image
Is Taysha Gene Therapies Gaining or Losing Market Support? ↗
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts ↗
Via Benzinga
News headline image
Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock ↗
Via Benzinga
News headline image
Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data ↗
Via Stocktwits
News headline image
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday? ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
The current price of Taysha Gene Therapies, Inc. - Common Stock is 5.140
When was Taysha Gene Therapies, Inc. - Common Stock last traded?
The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 331.35M
How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
Taysha Gene Therapies, Inc. - Common Stock has 331M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.